MedPath

Reducing relapse and recurrence in depression with continuation Cognitive Therapy.

Conditions
Recurrence or Relapse of Major Depression Disorder
Registration Number
NL-OMON25030
Lead Sponsor
Arkin, mental health care institute Amsterdam,Department of Psychology of the University of Groningen,Vanderbilt University, Nashville,Vrije Universiteit Amsterdam, Faculteit der Geneeskunde Huisarts- en Verpleeghuisgeneeskunde,Trimbos Instituut, Innovation Centre of Mental Health & Technology,Vrije Universiteit Amsterdam, Faculteit der Aard- en Levenswetenschappen Gezondheidswetenschappen: Health Economics and Technology Assessment
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
214
Inclusion Criteria

1. Two or more previous depressive episodes indicating high risk for relapse/recurrence;

2. In remission according to DSM-IV criteria;

Exclusion Criteria

1. Current mania or hypomania or a history of bipolar illness;

2. Any psychotic disorder (current and previous);

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is the cumulative proportion of relapses/recurrences in a survival-analysis over a follow-up period of 15 months after the start of the preventive therapy as measured with the ‘Structural Interview for DSM-IV (SCID) using the Longitudinal Interval Follow-up Evaluation (LIFE), which provides a retrospective assessment of depression recurrences since the time of the last evaluation.
Secondary Outcome Measures
NameTimeMethod
1. The severity of depressive symptoms as measured with the 'Inventory of Depression Symptomatology' (IDS-SR);<br /><br>2. Number of relapses (SCID);<br /><br>3. Anxiety (SCID);<br /><br>4. Suicidal thoughts (SCID);<br /><br>5. Social and interpersonal functioning (IIP);<br /><br>6. Well-being, quality of life (EQ-5D);<br /><br>6. Consumption of mental health care and degree of work absence (TIC P).
© Copyright 2025. All Rights Reserved by MedPath